The Effectiveness of a Preoperative Blood Pressure Screening Program to Identify Undiagnosed Hypertension in Ambulatory Surgery Patients

Hypertension Clinical Trial

— Peri-op HTN  

Official title:

The Effectiveness of a Preoperative Blood Pressure Screening Program to Identify Undiagnosed Hypertension in Ambulatory Surgery Patients

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03678207
• Other study ID #: 2018-0914
• Status: Withdrawn
• Start date: June 20, 2018
• Est. completion date: June 19, 2019

Study information

• Verified date: October 2019
• Source: Hospital for Special Surgery, New York
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Elevated blood pressure is the largest contributing risk factor to all-cause and cardiovascular mortality. According to the U.S. Preventive Services Task Force, hypertension affects nearly 30% of the adult population. Many patients remain undiagnosed, despite the consensus that screening and timely diagnosis is paramount. In this study, 108 ambulatory surgery patients with elevated blood pressure (160/90) that are not yet formally diagnosed with hypertension will be enrolled and alerted of their high blood pressure by a co-investigator MD. They will request permission to follow-up with the patient and the patient's primary care provider 6 months after the initial phone call to check in on the status of their diagnosis and any action taken (lifestyle changes, medication) to alleviate their high blood pressure. Patients will receive a follow-up letter/email at 6 and 3 months to remind them of their potential diagnosis.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: June 19, 2019
• Est. primary completion date: June 19, 2019
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients undergoing elective ambulatory surgery

• Patients with a pre-operative elevated BP defined as greater than 160/90

• Patients above the age of 18

• English speaking

Exclusion Criteria:

• Patients with a pre-existing diagnosis of HTN

• Patients who are taking a hypertensive medication

• Patients who had a pre-operative surgical screening assessment

Related Conditions & MeSH terms

• Hypertension
• Perioperative Hypertension

Intervention

Other:
• Anesthesiologist phone call
Patients receiving ambulatory surgery with no prior diagnosis of hypertension but have elevated blood pressure prior to surgery. Patients will receive a phone call from a participating anesthesiologist 1-3 days after surgery notifying them of their high blood pressure and obtaining oral consent to participate in the study. Patients will receive reminders via mail about following up with their PCP.

Locations

Country	Name	City	State
United States	Hospital for Special Surgery	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Hospital for Special Surgery, New York

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diagnosis of hypertension 6 months after surgery	The number of patients with previously undiagnosed hypertension that have obtained a formal diagnosis of hypertension	6 months postoperative
Secondary	PCP follow up 6 months after surgery	Number of patients that followed-up with a primary care physician for further hypertension testing within 6 months of surgery	6 months postoperative
Secondary	Hypertension treatment 6 months after surgery	Number of patients that followed-up for their hypertension that received some sort of treatment, either medication or lifestyle	6 months postoperative